Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.

Authors
Category Primary study
JournalLancet (London, England)
Year 1999
Combined chemotherapy for early breast cancer with cyclophosphamide, methotrexate, and fluorouracil has low associated mortality, but related deaths were seen among women aged 65 years or older in International Breast Cancer Study Group trials.
Epistemonikos ID: 23a64cea9790110be3dea31f8ba5eea9222f8122
First added on: Sep 12, 2023